Patents by Inventor Bernard F. Godley

Bernard F. Godley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photokinetic Ocular Drug Delivery Methods and Apparatus
    Publication number: 20150157715
    Abstract: The present invention relates generally to transscleral, transcorneal, and transocular delivery of biologically active substances through the tissues, blood vessels and cellular membranes of the eyes of patients without causing damage to the cellular surface, tissue or membrane. The invention provides compositions and methods for enhanced transscleral, transcorneal and transocular delivery of biologically active substances using pulsed incoherent light, and particularly the transcleral, transcorneal or transocular delivery of high molecular weight biologically active substances to a patient using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes of the eye of a subject using those compositions and methods.
    Type: Application
    Filed: January 29, 2015
    Publication date: June 11, 2015
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Edward R. Kraft, Gabriela A. Kulp, Bernard F. Godley, Aristides P. Koutrouvelis
  • Photokinetic ocular drug delivery methods and apparatus
    Patent number: 8948863
    Abstract: The present invention relates generally to transscleral, transcorneal, and transocular delivery of biologically active substances through the tissues, blood vessels and cellular membranes of the eyes of patients without causing damage to the cellular surface, tissue or membrane. The invention provides compositions and methods for enhanced transscleral, transcorneal and transocular delivery of biologically active substances using pulsed incoherent light, and particularly the transcleral, transcorneal or transocular delivery of high molecular weight biologically active substances to a patient using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes of the eye of a subject using those compositions and methods.
    Type: Grant
    Filed: October 12, 2010
    Date of Patent: February 3, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Edward R. Kraft, Gabriela A. Kulp, Bernard F. Godley, Aristides P. Koutrouvelis
  • PHOTOKINETIC OCULAR DRUG DELIVERY METHODS AND APPARATUS
    Publication number: 20110125076
    Abstract: The present invention relates generally to transscleral, transcorneal, and transocular delivery of biologically active substances through the tissues, blood vessels and cellular membranes of the eyes of patients without causing damage to the cellular surface, tissue or membrane. The invention provides compositions and methods for enhanced transscleral, transcorneal and transocular delivery of biologically active substances using pulsed incoherent light, and particularly the transcleral, transcorneal or transocular delivery of high molecular weight biologically active substances to a patient using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes of the eye of a subject using those compositions and methods.
    Type: Application
    Filed: October 12, 2010
    Publication date: May 26, 2011
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Edward R. Kraft, Gabriela A. Kulp, Bernard F. Godley, Aristides P. Koutrouvelis
  • Methods of inhibiting retinal pigment epithelial cell degeneration, stable cell lines, and uses
    Publication number: 20020052332
    Abstract: The present invention provides methods for inhibiting the degeneration of retinal pigment epithelial cells, which can reduce the incidence of, or delay the onset of, age-related macular degeneration, particularly in the early stages of AMD or in individuals at high risk for the disease.
    Type: Application
    Filed: April 11, 2001
    Publication date: May 2, 2002
    Applicant: The Board of Regents, University of Texas System
    Inventor: Bernard F. Godley